Proficio Capital Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,783
| Closed | -$1.44M | – | 481 |
|
|
2025
Q1 | $1.44M | Buy |
17,783
+6,915
| +64% | +$560K | 0.11% | 101 |
|
|
2024
Q4 | $979K | Buy |
10,868
+5,225
| +93% | +$471K | 0.08% | 108 |
|
|
2024
Q3 | $558K | Sell |
5,643
-30,792
| -85% | -$3.04M | 0.06% | 136 |
|
|
2024
Q2 | $3.38M | Sell |
36,435
-1,967
| -5% | -$182K | 0.35% | 51 |
|
|
2024
Q1 | $3.64M | Buy |
38,402
+11,702
| +44% | +$1.11M | 0.4% | 49 |
|
|
2023
Q4 | $2.38M | Sell |
26,700
-17,021
| -39% | -$1.52M | 0.29% | 51 |
|
|
2023
Q3 | $3.19M | Sell |
43,721
-18,199
| -29% | -$1.33M | 0.43% | 39 |
|
|
2023
Q2 | $5.15M | Buy |
61,920
+11,030
| +22% | +$918K | 0.7% | 24 |
|
|
2023
Q1 | $3.88M | Sell |
50,890
-28,463
| -36% | -$2.17M | 0.62% | 26 |
|
|
2022
Q4 | $5.38M | Buy |
79,353
+2,062
| +3% | +$140K | 1.02% | 17 |
|
|
2022
Q3 | $6.13M | Buy |
+77,291
| New | +$6.13M | 1.13% | 16 |
|
|
2019
Q2 | – | Sell |
-72
| Closed | -$7K | – | 2101 |
|
|
2019
Q1 | $7K | Buy |
+72
| New | +$7K | ﹤0.01% | 1027 |
|
|
2018
Q4 | – | Sell |
-1,600
| Closed | -$153K | – | 1285 |
|
|
2018
Q3 | $153K | Buy |
+1,600
| New | +$153K | 0.05% | 146 |
|